HCV NS3 1406-1415 (HLA-A*02:01) KLVALGINAV
€105.00*
Description
HCV NS3 1406-1415 with the amino acid sequence KLVALGINAV is a high quality peptidic epitope that is studied as part of Genome polyprotein from Hepatitis C virus. Single peptide (KLVALGINAV) for stimulation of human HCV NS3 (1406-1415)-specific CD8+ T cells. The peptide is synthesized as it is presented by the MHC class I HLA-A*02:01 allele.
TechData
| Sequence: | KLVALGINAV |
| Delivery: | 3 weeks |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Genome polyprotein |
| Species: | Hepatitis C virus (HCV) |
| Allele: | HLA-A*02:01 |
| Application: | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response |
| Indication: | Infectious disease |
| Purity: | 95% HPLC-MS |
More HCV peptides